We then assessed the expression of Prox1 and FOXC2 mRNA in 5 samples of non-tumor oral mucosa, 10 samples of metastasis-negative OSCCs, and 5 samples of metastasis-positive OSCCs (Fig. 2). The gene discussed is FOXC2; the disease is neoplasm.